Norlase is a developer of laser technologies intended to diagnose diabetes. Founded by David Hardwick, Oliver Hvidt, Peter Andersen, and Peter Skovgaard in 2014, Norlase is backed by investors that include West Hill Capital and is headquartered in Ballerup.